ArticleTherapeutic advances in medical oncology2024

Comparative safety of novel targeted therapies in relapsed/refractory chronic lymphocytic leukemia: a network meta-analysis.

Magdalena Monica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.